background
inflammatori
process
result
lung
injuri
may
lead
pulmonari
fibrosi
pf
describ
pf
mice
infect
viru
method
eightweekold
balbc
mice
inocul
intranas
mid
virus
lung
injuryfibrosi
evalu
observ
hydroxyprolin
concentr
lung
index
histopatholog
day
postinocul
result
mice
present
two
stage
pulmonari
diseas
period
infect
acut
stage
infectedmic
show
typic
diffus
pneumonia
inflammatori
cellular
infiltr
alveolar
interstiti
edema
hemorrhag
day
postinocul
restor
stage
infectedmic
develop
pf
differ
sever
day
postinocul
surviv
mice
underw
sever
interstiti
intraalveolar
fibrosi
thicken
alveolar
wall
collaps
alveoli
larg
fibrot
area
dramat
elev
hydroxyprolin
level
mice
show
deposit
collagen
lung
confirm
fibrosi
lung
dri
lungtobodi
weight
ratio
significantli
increas
infect
group
might
associ
format
pf
mice
find
show
mice
develop
typic
pf
restor
period
contribut
investig
fibrogenesi
potenti
therapeut
intervent
human
diseas
human
infect
avian
influenza
viru
bird
occur
success
sinc
first
case
report
hong
kong
demonstr
avian
influenza
viru
could
cross
speci
barrier
infect
human
possibl
avian
influenza
viru
mutat
abl
transmit
among
human
decemb
world
health
organ
report
viru
caus
human
infect
peopl
death
repres
mortal
rate
warn
substanti
risk
pandem
avian
influenza
near
futur
human
infect
character
sever
influenza
syndrom
includ
fever
cough
short
breath
radiolog
evid
pneumonia
almost
patient
clinic
appar
pneumonia
death
ensu
within
day
averag
onset
ill
patient
die
progress
respiratori
failur
believ
associ
acut
respiratori
distress
syndrom
ard
ard
common
devast
clinic
syndrom
acut
lung
injuri
high
mortal
rang
patholog
find
show
ard
patient
may
pulmonari
fibrosi
pf
convalesc
owe
damag
architectur
loss
function
capillari
unit
lung
idiopath
pulmonari
fibrosi
ipf
human
lead
respiratori
failur
within
year
follow
diagnost
confirm
may
correl
increas
risk
death
pf
result
consequ
mani
type
sever
lung
injuri
almost
alway
associ
inflammatori
reaction
viru
infect
sever
acut
respiratori
syndrom
sar
caus
novel
coronaviru
induc
typic
ard
pf
patient
eventu
die
also
possibl
patient
infect
virus
may
suffer
pf
result
ard
moreov
pandem
outbreak
avian
influenza
human
occur
major
consequ
ard
induc
viru
pf
may
prove
thorni
sequela
treatment
clinic
experi
avian
diseas
human
limit
patient
mostli
die
earli
period
pneumonia
know
littl
patholog
chang
lung
convalesc
laboratori
anim
provid
consider
insight
pathogenesi
complex
process
fibrosi
lung
previou
studi
show
viru
could
induc
typic
ard
mice
character
mortal
progress
hypoxemia
pulmonari
inflammatori
cellular
infiltr
alveolar
interstiti
edema
hemorrhag
studi
use
mous
model
investig
patholog
chang
restor
stage
induc
viral
infect
provid
basi
futur
investig
pathogenesi
pf
human
influenza
diseas
viru
use
isol
chicken
hebei
provinc
china
januari
identifi
avian
influenza
viru
mean
hemagglutin
inhibit
hi
neuraminidas
inhibit
test
isol
design
complet
genom
sequenc
viru
obtain
genbank
viru
caus
mortal
specif
pathogenfre
spf
chicken
within
day
intraven
infect
ml
infecti
allanto
fluid
dilut
viru
belong
highli
pathogen
avian
influenza
viru
accord
criteria
viral
virul
previou
studi
show
viru
highli
lethal
mice
could
caus
typic
ard
mice
viru
propag
allanto
caviti
embryon
spf
chicken
egg
h
thirdpassag
viru
gradient
purifi
store
use
manipul
live
virus
conduct
biosafeti
level
facil
eightwkold
femal
spf
balbc
mice
bodi
weight
g
purchas
beij
laboratori
anim
research
center
beij
peopl
republ
china
hous
microisol
cage
ventil
neg
pressur
hepafilt
air
experi
mice
given
food
water
ad
lib
previou
studi
show
dose
mous
infecti
dose
mid
viru
optim
observ
pf
dosag
cours
diseas
slightli
prolong
infect
mice
present
obviou
lung
injuri
pf
time
period
anim
infect
higher
dose
mid
mice
die
lower
dose
mid
lung
injuri
pf
demonstr
therefor
experi
mice
inocul
intranas
mid
viru
dilut
steril
salin
lightli
anesthet
diethyl
ether
mice
control
group
inocul
equival
dilut
noninfecti
allanto
fluid
manipul
perform
laboratori
condit
anim
experi
conduct
accord
establish
guidelin
approv
anim
care
committe
china
agricultur
univers
beij
peopl
republ
china
two
type
experi
carri
studi
first
experi
investig
mortal
clinic
sign
presenc
sever
pf
mice
time
period
experi
mice
divid
randomli
two
group
group
mice
inocul
viru
control
group
mice
receiv
noninfecti
allanto
fluid
describ
anim
gener
behavior
clinic
sign
includ
food
intak
bodi
weight
inact
anal
temperatur
measur
infrar
thermomet
mortal
monitor
daili
group
day
observ
food
intak
mice
hous
individu
grid
box
chang
twiceweek
weigh
daili
food
intak
measur
offer
daili
known
weight
food
separ
weigh
leftov
food
box
chang
day
infect
mice
surviv
sacrif
whole
lung
remov
assess
degre
pf
second
experi
character
develop
lung
injuri
pf
mice
viral
infect
mice
divid
randomli
two
group
mice
describ
experi
sinc
mice
die
day
day
postinocul
pi
larger
group
per
group
mice
use
viru
inocul
use
experi
four
mice
group
weigh
euthan
day
pi
whole
lung
remov
left
lobe
lung
fix
buffer
formalin
embed
paraffin
histopatholog
evalu
upper
part
right
lung
lobe
use
determin
lung
wettodri
weight
ratio
dri
lungtobodi
weight
ratio
remain
lobe
right
lung
store
determin
lung
hydroxyprolin
content
upper
part
right
lung
excis
weigh
oven
desicc
hour
calcul
index
accord
follow
formula
lung
wettodri
weight
ratio
weight
whole
wet
lungweight
whole
dri
lung
dri
lungtobodi
weight
ratio
weight
whole
dri
lungbodi
weight
fix
formalin
day
lung
tissu
embed
paraffin
serial
section
obtain
block
three
sagitt
section
lung
ie
six
section
per
anim
stain
hematoxylin
eosin
masson
trichrom
sever
pf
assess
specimen
number
randomli
interpret
experiment
blind
experiment
condit
visual
grade
pf
perform
determin
ashcroft
score
modif
briefli
entir
field
lung
section
scan
olympu
microscop
olympu
optic
co
ltd
magnif
field
visual
grade
criteria
grade
lung
fibrosi
follow
grade
normal
lung
grade
minim
fibrou
thicken
alveolar
bronchiolar
wall
grade
moder
thicken
wall
without
obviou
damag
lung
architectur
grade
increas
fibrosi
definit
damag
lung
structur
format
fibrou
band
small
fibrou
mass
grade
sever
distort
structur
larg
fibrou
area
grade
total
fibrou
obliter
lung
field
examin
whole
section
mean
score
field
taken
fibrosi
score
anim
lung
fibrosi
sever
mice
surviv
day
pi
classifi
grade
obviou
fibrosi
sever
fibrosi
accord
fibrosi
score
rang
shown
tabl
sinc
collagen
deposit
hallmark
fibrosi
collagen
contain
signific
amount
hydroxyprolin
lung
hydroxyprolin
measur
use
quantifi
sever
fibrosi
studi
accord
manufactur
instruct
hydroxyprolin
measur
use
test
kit
nanj
jiancheng
bio
china
estim
collagen
content
lung
briefli
lung
tissu
sampl
mice
weigh
hydrolyz
releas
hydroxyprolin
collagen
oxid
hydroxyprolin
chloramin
hydroxyprolin
chromogen
react
paradimethylaminobenzaldehyd
develop
pink
color
absorb
color
product
measur
nm
spectrophotometr
hydroxyprolin
content
sampl
calcul
compar
standard
data
express
microgram
hydroxyprolin
per
gram
wet
lung
weight
mice
inocul
intranas
mid
virus
lung
tissu
collect
day
pi
viru
titrat
embryon
egg
mean
viral
titer
calcul
base
three
mice
per
group
express
log
eid
per
millilit
sd
sever
pulmonari
fibrosi
assess
accord
modifi
ashcroft
score
describ
method
ms
mean
mean
score
lung
fibrosi
anim
three
sagitt
section
lung
ie
six
section
per
anim
data
analyz
statist
packag
social
scienc
spss
version
window
result
express
mean
sd
twotail
student
test
use
determin
differ
group
data
consid
statist
signific
p
clinic
gross
patholog
observ
mice
present
two
stage
clinic
sign
time
period
viral
inocul
acut
stage
onset
evolut
clinic
sign
follow
day
pi
slight
alter
gait
inact
ruffl
fur
inappet
weight
loss
day
pi
sever
inappet
emaci
visual
sign
labor
respir
respiratori
distress
fiftysix
percent
mice
die
stage
death
peak
day
pi
onset
inappet
inact
correl
loss
bodi
weight
continu
declin
death
bodi
temperatur
slightli
declin
infect
dramat
declin
mice
die
restor
stage
clinic
sign
surviv
anim
resolv
gradual
day
pi
disappear
almost
complet
day
howev
mice
surviv
acut
stage
develop
late
stage
diseas
acceler
assess
presenc
inact
weight
loss
inappet
emaci
macroscop
histopatholog
evalu
show
mice
present
sever
pf
figur
show
chang
bodi
weight
food
intak
viral
infect
infect
mice
induc
acut
reduct
bodi
weight
day
pi
caus
greater
decreas
bodi
weight
gain
day
pi
standard
deviat
bodi
weight
infect
mice
much
greater
control
mice
restor
period
day
indic
individu
differ
group
similar
chang
also
observ
food
intak
data
suggest
surviv
mice
compromis
qualiti
life
time
period
viral
infect
virusinfect
lung
significantli
heavier
normal
lung
figur
show
sever
consolid
edema
hepat
vari
degre
hemorrhag
figur
day
pi
day
pi
infect
anim
develop
massiv
pf
flesh
appear
one
lung
sever
emphysema
figur
suggest
unilater
lung
dysfunct
caus
fibrosi
manag
compens
lung
histopatholog
lesion
could
subclassifi
two
consecut
phase
initi
acut
exud
phase
final
fibrot
phase
although
consider
overlap
exist
histolog
find
two
phase
histopatholog
chang
lung
injuri
fibrosi
masson
stain
shown
figur
initi
exud
stage
infect
mice
present
typic
diffus
pneumonia
lesion
associ
ard
day
pi
interstiti
edema
around
small
blood
vessel
adher
inflammatori
cell
wall
small
vessel
figur
alveolar
wall
bodi
weight
food
intak
b
infect
mice
figur
bodi
weight
food
intak
b
infect
mice
uninfect
control
group
open
squar
virusinfect
group
solid
triangl
p
p
group
vs
control
group
data
present
mean
sd
mice
group
thicken
inflammatori
cell
infiltr
interstiti
intraalveolar
space
figur
day
pi
masson
stain
show
alveolar
space
widen
fill
collagen
fiber
figur
indic
prolif
fibroblast
lesion
may
develop
futur
alveolar
wall
gener
thicken
infiltr
inflammatori
cell
hyperplasia
type
ii
pneumocyt
hemorrhag
also
observ
interstitium
intraalveolar
space
figur
final
fibrot
stage
surviv
mice
develop
pf
differ
sever
day
pi
accord
ashcroft
method
sever
score
lung
fibrosi
surviv
mice
given
tabl
show
mice
minim
fibrosi
moder
fibrosi
underw
sever
fibrosi
low
power
magnif
sever
distort
structur
diffus
fibrou
area
observ
lung
field
figur
sever
affect
anim
typic
interstiti
fibrosi
lung
exhibit
greatli
thicken
alveolar
wall
prolifer
cell
accumul
matrix
interstiti
space
bound
epitheli
endotheli
basement
membran
figur
diffus
intraalveolar
airspac
fibrosi
common
find
stage
larg
fibrou
area
seen
excess
collagen
deposit
cell
prolifer
airspac
obliter
alveolar
space
organ
lung
parenchyma
sever
distort
lung
figur
bronchiolar
wall
thicken
numer
fibroblast
prolifer
protrud
lumen
lead
bronchiolar
stenosi
figur
solid
arrow
addit
focal
alveolar
collaps
secondari
apposit
alveolar
wall
observ
section
figur
alveolar
ectasia
airspac
fibrosi
also
found
field
lung
figur
lung
tissu
control
group
show
normal
architectur
open
pattern
alveolar
space
thinlin
alveolar
septa
alveolar
macrophag
minim
collagen
deposit
hydroxyprolin
amino
acid
found
almost
exclus
collagen
reflect
collagen
deposit
lung
therefor
lung
hydroxyprolin
measur
provid
direct
measur
format
pf
studi
lung
hydroxyprolin
content
shown
figur
measur
day
pi
day
pi
group
show
signific
decreas
lung
hydroxyprolin
content
compar
control
anim
might
reflect
develop
sever
lung
edema
infect
mice
lung
hydroxyprolin
level
return
normal
day
pi
increas
almost
twofold
day
pi
compar
control
mice
chang
hydroxyprolin
content
consist
histopatholog
find
demonstr
format
pf
day
infect
figur
show
effect
viral
infect
lung
wettodri
weight
ratio
dri
lungtobodi
weight
ratio
mice
two
ratio
chang
obvious
day
pi
dramat
elev
day
pi
suggest
sever
edema
inflammatori
exud
lung
ratio
infect
mice
return
control
level
day
pi
indic
edema
inflammatori
exud
reabsorb
day
pi
surviv
mice
show
significantli
decreas
lung
wettodri
weight
ratio
dramat
increas
dri
lungtobodi
weight
ratio
might
associ
format
pf
mice
viral
infect
made
high
titer
virus
lung
day
pi
shown
figur
peak
viral
titer
appear
day
pi
virus
detect
level
day
pi
report
focus
develop
pf
mice
intranas
infect
mid
chicken
viru
typic
ard
observ
earli
period
viral
infect
infect
mice
exhibit
clinic
sign
respiratori
distress
mice
die
day
pi
macroscop
observ
show
infect
mice
highli
edemat
lung
day
pi
also
demonstr
dramat
increas
lung
wettodri
weight
ratio
microscop
level
infect
mice
exhibit
typic
diffus
pneumonia
obviou
ardsassoci
patholog
chang
includ
fulli
develop
bronchiol
peribronchiolar
pneumonia
character
inflammatori
cellular
infiltr
interstiti
alveolar
edema
hemorrhag
data
consist
previou
studi
infect
mice
develop
pf
gradual
late
stage
day
pi
surviv
mice
underw
sever
fibrosi
accord
ashcroft
method
typic
interstiti
intraalveolar
fibrosi
observ
thicken
alveolar
wall
collaps
alveoli
larg
organ
area
intraalveolar
fibrosi
ectasia
show
simultan
lung
specimen
reactiv
hyperplasia
pneumocyt
present
organ
phase
bronchiolar
stenosi
result
thicken
bronchiolar
wall
prolifer
fibroblast
also
found
light
microscop
moreov
import
index
fibrosi
hydroxyprolin
level
increas
significantli
mice
compar
control
group
day
pi
show
deposit
collagen
lung
confirm
fibrosi
lung
restor
period
clinic
sign
anim
resolv
gradual
day
pi
disappear
almost
complet
day
howev
mice
surviv
acut
stage
develop
acceler
diseas
progress
late
stage
assess
presenc
inact
weight
loss
inappet
emaci
macroscop
histopatholog
evalu
show
mice
present
sever
pf
data
show
surviv
mice
fibrot
lung
sever
compromis
qualiti
life
well
establish
lung
subject
inflammatori
reaction
return
preinflammatori
state
viral
pneumonia
includ
viral
infect
caus
intens
lung
histopatholog
shown
masson
trichrom
stain
infect
mice
figur
see
previou
page
lung
histopatholog
shown
masson
trichrom
stain
infect
mice
day
pi
infect
mice
present
typic
diffus
pneumonia
interstiti
edema
around
small
blood
vessel
figur
solid
arrow
inflammatori
cell
thicken
alveolar
wall
figur
open
arrow
day
pi
masson
stain
show
widen
alveolar
space
collagen
fiber
figur
open
arrow
thicken
alveolar
wall
infiltr
inflammatori
cell
hyperplasia
pneumocyt
figur
solid
arrow
day
pi
sever
distort
structur
diffus
fibrou
area
observ
lung
field
figur
low
magnif
anim
display
typic
interstiti
fibrosi
lung
character
greatli
thicken
alveolar
wall
cell
prolifer
matrix
accumul
interstiti
space
figur
solid
arrow
diffus
intraalveolar
fibrosi
common
find
excess
collagen
deposit
cell
prolifer
airspac
obliter
alveolar
space
sever
distort
structur
figur
solid
arrow
figur
open
arrow
thicken
bronchiolar
wall
prolifer
fibroblast
lead
bronchiolar
stenosi
figur
solid
arrow
addit
focal
alveolar
collaps
figur
solid
arrow
alveolar
ectasia
figur
hydroxyprolin
content
lung
infect
mice
figur
hydroxyprolin
content
lung
infect
mice
level
lung
hydroxyprolin
virusinfect
mice
solid
bar
control
mice
open
bar
determin
use
test
kit
shown
mean
sd
mice
group
p
compar
control
mice
inflammatori
process
lung
fibrosi
rather
resolut
might
becom
inevit
outcom
experi
found
secondari
bacteri
infect
titer
virus
lung
detect
level
day
pi
data
like
reflect
clinic
patholog
evolut
ard
fibrosi
lung
subsequ
infect
mice
human
fibrosi
lung
correl
respiratori
failur
increas
risk
death
sever
postmortem
report
patient
influenza
demonstr
presenc
organ
diffus
alveolar
damag
interstiti
fibrosi
pressur
pandem
humanavian
influenza
near
futur
must
prepar
prevent
spread
viru
find
effect
method
revers
relentless
progress
pf
induc
viral
infect
research
may
provid
valuabl
mous
model
studi
develop
diseas
search
treatment
human
influenza
present
pathogenesi
pf
fulli
understood
studi
show
cytokin
transform
growth
plateletderiv
growth
factor
pdgf
appear
import
role
control
fibroblast
activ
vitro
implic
pathogenesi
pf
pf
difficult
treat
clinic
drug
use
corticosteroid
therapi
like
dexamethason
current
firstlin
choic
prevent
diseas
antiinflammatori
effect
laboratori
studi
show
corticosteroid
might
prevent
collagen
overexpress
decreas
upregul
cytokin
includ
bleomycininduc
pf
model
studi
use
mous
model
focu
role
cytokin
pathogenesi
pf
effect
drug
pf
induc
viru
find
show
mice
develop
typic
pf
restor
period
result
ard
contribut
investig
fibrogenesi
potenti
therapeut
intervent
human
diseas
lung
wettodri
weight
ratio
dri
lungtobodi
weight
ratio
b
infect
mice
figur
lung
wettodri
weight
ratio
dri
lungtobodi
weight
ratio
b
infect
mice
uninfect
control
group
open
bar
virusinfect
group
solid
bar
p
virusinfect
group
vs
control
group
valu
present
mean
sd
mice
group
figur
replic
viru
mous
lung
mice
inocul
intranas
mid
viru
virus
titrat
embryon
egg
mean
viral
titer
solid
bar
calcul
base
three
mice
per
group
